IL-6, IL-8, and IL-10 Are Associated with Hyperferritinemia in Rapidly Progressive Interstitial Lung Disease with Polymyositis/Dermatomyositis

Table 1

Clinical characteristics in the enrolled patients*.

	(𝑛=38)
Age, years	52 (39–58)
Female, number (%)	28 (74)
PM, DM, and CADM, number	12, 14, 12
Disease duration, month	4 (2–7)
Interstitial lung disease, number (%)	21 (55)
Rapidly progressive, number (%)	10 (26)
Chronic, number (%)	11 (29)
Myositis-specific autoantibodies, number (%)
Anti-ARS	12 (32)
Anti-Mi-2	1 (3)
Anti-MDA-5	10 (26)
Anti-SRP	2 (5)

∗Thirty-eight patients were enrolled in the present study.
Values are median (interquartile range).
PM: polymyositis; DM: dermatomyositis; CADM: clinically amyopathic DM; ARS: aminoacyl-tRNA synthetase; MDA-5: melanoma differentiation-associated gene 5; and SRP: signal recognition particle.